In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS)
Open Access
- 15 January 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 63 (3) , 620-622
- https://doi.org/10.1093/jac/dkn532
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infectionsExpert Opinion on Investigational Drugs, 2008
- Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004)Journal of Antimicrobial Chemotherapy, 2007
- Clinical implications of macrolide resistance in community-acquired respiratory tract infectionsExpert Review of Anti-infective Therapy, 2006
- The use of macrolides in treatment of upper respiratory tract infectionsCurrent Infectious Disease Reports, 2005
- Telithromycin activity is reduced by efflux in Streptococcus pyogenesJournal of Antimicrobial Chemotherapy, 2005
- Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrationsJournal of Antimicrobial Chemotherapy, 2004